A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis

Osteoporosis, a systemic skeleton disease, can be prevented by increasing calcium levels in serum via administration of calcium salts. However, traditional calcium-based formulations have not appeared to be effective, hence the purpose of the present work has been to prepare and test in vitro/vivo a...

Full description

Bibliographic Details
Main Authors: Angela Fabiano, Anna Maria Piras, Vincenzo Calderone, Lara Testai, Lorenzo Flori, Dario Puppi, Federica Chiellini, Ylenia Zambito
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/11/10/2467
id doaj-095644ec85b84b95a502ca50e656a920
record_format Article
spelling doaj-095644ec85b84b95a502ca50e656a9202020-11-25T00:39:42ZengMDPI AGNutrients2072-66432019-10-011110246710.3390/nu11102467nu11102467A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of OsteoporosisAngela Fabiano0Anna Maria Piras1Vincenzo Calderone2Lara Testai3Lorenzo Flori4Dario Puppi5Federica Chiellini6Ylenia Zambito7Department of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyDepartment of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyDepartment of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyDepartment of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyDepartment of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyDepartment of Chemistry and Industrial Chemistry, University of Pisa, Udr INSTM Pisa, Via Moruzzi 13, 56124 Pisa, ItalyDepartment of Chemistry and Industrial Chemistry, University of Pisa, Udr INSTM Pisa, Via Moruzzi 13, 56124 Pisa, ItalyDepartment of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyOsteoporosis, a systemic skeleton disease, can be prevented by increasing calcium levels in serum via administration of calcium salts. However, traditional calcium-based formulations have not appeared to be effective, hence the purpose of the present work has been to prepare and test in vitro/vivo a formulation able to gradually release calcium during transit over the GI tract, thus increasing bioavailability and reducing daily dose, and hence, side effects. Calcium controlled-release granules based on zeolite and Precirol<sup>&#174;</sup> were prepared. In the best case, represented by granules sized 1.2 mm, containing 20% Precirol<sup>&#174;</sup>, 19% zeolite, 60% calcium (granule), the release lasted &#8776;6 h. The release is controlled by diffusion of calcium ions through the aqueous channels forming within granules, once these come into contact with physiological fluids. Such a diffusion is hindered by the interaction of calcium ions with the negatively charged surface of the zeolite. Ovariectomy was used to make rats osteopenic. For in vivo studies, rats were divided into the following groups. Sham: not treated; ova: ovariectomized (ova); CaCl<sub>2</sub> 1.0 g: ova, treated with 1.0 g/die Ca<sup>2+</sup>; CaCl<sub>2</sub> 0.5 g: ova, treated with 0.5 g/die Ca<sup>2+</sup>; granule 1.0 g, or granule 0.5 g: ova, treated with granules equivalent to 1.0 g/die or 0.5 g/die Ca<sup>2+</sup> in humans. Ca<sup>2+</sup> amounts in femur bone and bone marrow, femur mechanical characteristics, and femur medullary canalicule diameter were measured and the same efficacy rank order was obtained: ova &lt; CaCl<sub>2</sub> 0.5 g &lt; CaCl<sub>2</sub> 1.0 g &lt; granule 0.5 g &#8776; granule 1.0 g &#8776; sham. The results show promise of an effective prevention of osteoporosis, based on a controlled-rate administration of a calcium dose half that administered by the current therapy, with reduced side effects.https://www.mdpi.com/2072-6643/11/10/2467calcium zeoliteprecirol<sup>®</sup> granulescalcium controlled releaseosteopenic ratsfemur mechanical characterizationfemur morphological characterization
collection DOAJ
language English
format Article
sources DOAJ
author Angela Fabiano
Anna Maria Piras
Vincenzo Calderone
Lara Testai
Lorenzo Flori
Dario Puppi
Federica Chiellini
Ylenia Zambito
spellingShingle Angela Fabiano
Anna Maria Piras
Vincenzo Calderone
Lara Testai
Lorenzo Flori
Dario Puppi
Federica Chiellini
Ylenia Zambito
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis
Nutrients
calcium zeolite
precirol<sup>®</sup> granules
calcium controlled release
osteopenic rats
femur mechanical characterization
femur morphological characterization
author_facet Angela Fabiano
Anna Maria Piras
Vincenzo Calderone
Lara Testai
Lorenzo Flori
Dario Puppi
Federica Chiellini
Ylenia Zambito
author_sort Angela Fabiano
title A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis
title_short A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis
title_full A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis
title_fullStr A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis
title_full_unstemmed A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis
title_sort new calcium oral controlled-release system based on zeolite for prevention of osteoporosis
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2019-10-01
description Osteoporosis, a systemic skeleton disease, can be prevented by increasing calcium levels in serum via administration of calcium salts. However, traditional calcium-based formulations have not appeared to be effective, hence the purpose of the present work has been to prepare and test in vitro/vivo a formulation able to gradually release calcium during transit over the GI tract, thus increasing bioavailability and reducing daily dose, and hence, side effects. Calcium controlled-release granules based on zeolite and Precirol<sup>&#174;</sup> were prepared. In the best case, represented by granules sized 1.2 mm, containing 20% Precirol<sup>&#174;</sup>, 19% zeolite, 60% calcium (granule), the release lasted &#8776;6 h. The release is controlled by diffusion of calcium ions through the aqueous channels forming within granules, once these come into contact with physiological fluids. Such a diffusion is hindered by the interaction of calcium ions with the negatively charged surface of the zeolite. Ovariectomy was used to make rats osteopenic. For in vivo studies, rats were divided into the following groups. Sham: not treated; ova: ovariectomized (ova); CaCl<sub>2</sub> 1.0 g: ova, treated with 1.0 g/die Ca<sup>2+</sup>; CaCl<sub>2</sub> 0.5 g: ova, treated with 0.5 g/die Ca<sup>2+</sup>; granule 1.0 g, or granule 0.5 g: ova, treated with granules equivalent to 1.0 g/die or 0.5 g/die Ca<sup>2+</sup> in humans. Ca<sup>2+</sup> amounts in femur bone and bone marrow, femur mechanical characteristics, and femur medullary canalicule diameter were measured and the same efficacy rank order was obtained: ova &lt; CaCl<sub>2</sub> 0.5 g &lt; CaCl<sub>2</sub> 1.0 g &lt; granule 0.5 g &#8776; granule 1.0 g &#8776; sham. The results show promise of an effective prevention of osteoporosis, based on a controlled-rate administration of a calcium dose half that administered by the current therapy, with reduced side effects.
topic calcium zeolite
precirol<sup>®</sup> granules
calcium controlled release
osteopenic rats
femur mechanical characterization
femur morphological characterization
url https://www.mdpi.com/2072-6643/11/10/2467
work_keys_str_mv AT angelafabiano anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT annamariapiras anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT vincenzocalderone anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT laratestai anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT lorenzoflori anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT dariopuppi anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT federicachiellini anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT yleniazambito anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT angelafabiano newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT annamariapiras newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT vincenzocalderone newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT laratestai newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT lorenzoflori newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT dariopuppi newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT federicachiellini newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
AT yleniazambito newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis
_version_ 1725293049608667136